It is important to note, however, that reductions in antibody production, plasmablasts, and memory B cell affinity maturation were also observed in patients with IBD treated with agents that block lymphocyte migration to mucosal tissues or inhibit IL-12 and IL-23 or cell division but do not interfere directly with TNF. The gene discussed is TNF; the disease is inflammatory bowel disease.